Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 13252
TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771413(US12415799, Compound 4)
Affinity DataIC50: 1.11E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771412(US12415799, Compound 3)
Affinity DataIC50: 1.36E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771416(US12415799, Compound 11A)
Affinity DataIC50: 2.57E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771415(US12415799, Compound 10)
Affinity DataIC50: 3.08E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771414(US12415799, Compound 8)
Affinity DataIC50: 4.21E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771411(US12415799, Compound 2)
Affinity DataIC50: 4.72E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771415(US12415799, Compound 10)
Affinity DataIC50: 4.75E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771411(US12415799, Compound 2)
Affinity DataIC50: 5.00E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771412(US12415799, Compound 3)
Affinity DataIC50: 5.00E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771413(US12415799, Compound 4)
Affinity DataIC50: 5.00E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771414(US12415799, Compound 8)
Affinity DataIC50: 5.00E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Zhejiang Yangli Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM771416(US12415799, Compound 11A)
Affinity DataIC50: 5.00E+4nMAssay Description:Experimental operation: Firstly, the test compound (10 mM) was subjected to gradient dilution to prepare a working solution (100×final concentration)...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/29/2025
Entry Details
US Patent